药物开发
加速推进科学发展
在 BMS，你每天都会因我们治疗领域早期和后期开发中既有趣又有意义的工作而受到鼓舞。通过临床研究、数据科学和我们的战略运营，我们引领创新，为患者提供创新药物和疗法。
在药物开发的各个阶段，你会获得丰富的挑战机会。它绝不简单，但绝对有趣。你将在这里改写规则、应对艰巨挑战并创造奇迹。
Guiding the Vision for Drug Development
Living the mission of transforming patients’ lives through science, Drug Development leadership continue to inspire and be inspired by the incredible work happening now:
Meet our team
药品开发职业发展机会
BMS 药物开发部门为具备相关技能和专业知识的人才提供丰富的职业发展机会。无论你是对开发、数据科学、患者安全，还是战略运营感兴趣，都有机会为新药开发做出贡献。
为癌症和血液疾病治疗领域（包括细胞治疗）的药物开发工作做贡献。
为免疫学、心血管和神经科学领域的药物开发提供支持，向患者提供最佳治疗方法。
利用数据和机器学习技术推动定量决策、加速药物开发，改善患者治疗结果。
利用运营科学成功将我们的系列药品推向市场。
通过全球创新注册策略和卓越运营建立合作关系，为患者提供药品，同时塑造未来科学监管与政策。
妥善管理我们的产品组合，使公司的价值得到优化和最大化。
Our Areas of Focus
Development Hematology, Oncology, Cell Therapy (HOCT)
- Development Hematology, Oncology, Cell Therapy (HOCT)
- Development Immunology, Cardiovascular, Neuroscience (ICN)
- Global Biometrics & Data Sciences
- 全球开发运营
- 全球注册科学
- 产品组合与战略运营
- 全球患者安全
Development Hematology, Oncology, Cell Therapy (HOCT)
In Hematology, Oncology, and Cell Therapy we are passionate about developing transformative therapies for patients with serious diseases. Our team executes with urgency to drive groundbreaking strategies, demonstrating exceptional scientific understanding of the underlying disease biology of clinical unmet need alongside deep technical development experience to deliver our broad hematology, oncology, and cell therapy portfolio. Our industry-leading team strives to unlock the full promise of our innovative treatments to help more patients, faster.
团队分别位于： Boudry, Switzerland; California Bay Area; China, New Jersey, Seattle, WA
Development Immunology, Cardiovascular, Neuroscience (ICN)
The Immunology, Cardiovascular & Neuroscience Development organization aspires to develop and deliver innovative medicines to patients globally, addressing high unmet medical needs and transforming the lives of patients. Working cross-functionally in matrixed teams to accelerate development of new therapies, our focus on people empowers decision making at all levels of the organization.
团队分别位于： Boudry, Switzerland; California Bay Area; Cambridge, MA; China; New Jersey; San Diego, CA
Global Biometrics & Data Sciences
The Global Biometrics and Data Sciences (GBDS) team provides value to R&D through their multifaceted support. Firstly, they support exploratory research design and analysis (EDTs) by collaborating in the exploration of biomarkers, utilizing a quantitative decision framework to progress assets from early to late stage (GT4), and in clinical development they support registrational study design and analysis (FDTs) by engaging regulators, responding to global Health Authorities, supporting publications/findings at medical congresses (e.g., ASCO), and informing/developing regulatory submissions. Lastly, the GBDS team ensures the appropriate scientific interpretation of data and asset value, expands upon clinical trial data to support key messages for payers and HCPs, and supports publications, Investigator Sponsored Research (ISRs), and Market Access needs (e.g., pricing and reimbursement). By providing these three areas of support, the GBDS team plays a critical role in advancing drug development and ensuring that our products are accessible to patients who need them.
团队分别位于： Boudry, Switzerland; California Bay Area; Cambridge, MA; China; Hyderabad, India; New Jersey; San Diego, CA
全球开发运营
Conducting clinical trials is one of the company’s most critical pursuits to develop and bring new medicines to patients in need. Global Development Operations (GDO) leverages the science of clinical operations to plan, manage and execute BMS clinical trials across over 40 countries and 40 disease areas. GDO’s core strategy is to build and sustain superior clinical trial execution, collaborating and innovating on behalf of BMS patients and sites while never compromising on ethics, integrity, and compliance.
团队分别位于： Boudry, Switzerland; China; Hyderabad, India; New Jersey; San Diego, CA
全球注册科学
Global Regulatory Sciences (GRS) serves as a trusted partner in delivering medicines to patients through innovative global regulatory strategies and operational excellence while shaping the future of regulatory science and policy.
团队分别位于： Boudry, Switzerland; Hyderabad, India; New Jersey
产品组合与战略运营
The Portfolio & Strategic Operations Organization (P&SO) enables end-to-end portfolio strategy execution through integrated capabilities which drive strategic portfolio and business operational excellence through portfolio planning and reporting, resource management, strategic initiatives, clinical excellence, learning platforms and business continuity/risk management - as the business engine for Drug Development.
团队分别位于： Boudry, Switzerland; California Bay Area; Cambridge, MA; China; New Jersey; San Diego, CA; Seattle, WA
全球患者安全
At BMS, Worldwide Patient Safety (WWPS) is uniquely committed to safeguarding the patients we serve. Through industry leading pharmacovigilance and risk management capabilities, we ensure the safety profile of BMS medicines is well-characterized and our patients have access to trusted and reliable information to optimize their safe and informed use.
团队分别位于： Boudry, Switzerland; China; New Jersey
我们位于印度海得拉巴 (Hyderabad) 的技术与创新中心
BMS 海得拉巴的综合性全球中心，致力于通过建立可持续创新解决方案，帮助患者战胜严重疾病。我们在海得拉巴的研发组织将帮助建立重要能力部门，为药物开发周期中的注册、生物统计学、运营和临床科学等重要阶段提供支持。这项工作将进一步加速我们的药物开发并推动 BMS 践行使命，发现、开发和提供惠及患者的创新药物。
职业故事
看看我们世界各地的药物开发团队成员每天如何为患者工作。
